Registration Rights
The holders of the (i) founder shares, which were issued in a private placement prior to and at the closing of the Initial Public Offering, (ii) private placement warrants, which will be issued in a private placement concurrently with the closing of the Initial Public Offering and the Class A ordinary shares underlying such private placement warrants and (iii) private placement warrants that may be issued upon conversion of working capital loans will have registration rights to require us to register a sale of any of our securities held by them pursuant to a registration rights agreement. Pursuant to the registration rights agreement and assuming the underwriters exercise their over-allotment option in full and $1,500,000 of working capital loans are converted into private placement warrants, we will be obligated to register up to 11,816,667 Class A ordinary shares and 6,066,667 warrants. The number of Class A ordinary shares includes (i) 5,750,000 Class A ordinary shares to be issued upon conversion of the founder shares, (ii) 5,066,667 Class A ordinary shares underlying the private placement warrants and (iii) 1,000,000 Class A ordinary shares underlying the private placement warrants issued upon conversion of working capital loans. The number of warrants includes 5,066,667 private placement warrants and up to 1,000,000 additional private placement warrants issuable upon conversion of working capital loans. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
Equity Compensation Plans
As of December 31, 2022, we had no compensation plans (including individual compensation arrangements) under which equity securities were authorized for issuance.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
In March 2021, an affiliate of our sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs, in exchange for an aggregate of 5,750,000 founder shares, which were subsequently transferred to our sponsor.
Our sponsor committed, pursuant to a written agreement, to purchase an aggregate of 4,666,667 private placement warrants (or 5,066,667 warrants if the underwriters’ over-allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per whole warrant, or $7,000,000 in the aggregate (or $7,600,000 if the underwriters’ over-allotment option is exercised in full), in a private placement that occurred concurrently with the closing of the IPO. On November 30, 2021, the underwriters purchased an additional 1,240,488 Option Units pursuant to the partial exercise of the Over-Allotment Option. The Option Units were sold at an offering price of $10.00 per Unit, generating aggregate additional gross proceeds of $12,404,880 to the Company.
On November 30, 2021, in connection with the underwriter’s partial exercise of the over-allotment option, our sponsor surrendered 439,878 founder shares. Also in connection with the partial exercise of the Over-Allotment Option, the Sponsor purchased an additional 165,398 warrants at a purchase price of $1.50 per whole warrant. The private placement warrants are identical to the warrants sold in the IPO except that the private placement warrants, so long as they are held by our sponsor or its permitted transferees, (i) will not be redeemable by us, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights. The private placement warrants may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder. If we do not complete our initial business combination by October 19, 2023, the private placement warrants will expire worthless. The private placement warrants are subject to the transfer restrictions described below.
Certain institutions, who we refer to as “sponsor members” throughout this Annual Report, are members in, but are not affiliates of our sponsor. Such “sponsor members” are (i) certain funds and accounts managed by or affiliated with Sea Otter Securities Group LLC, Sculptor Capital LP, Meteora Capital LLC, Magnetar Financial LLC, Greytail Cove I LLC, Major Tom Private Capital LLC, Atalaya Capital Management LP and Corbin Capital Partners, L.P., Radcliffe Capital Management, L.P., Basso SPAC Fund LLC and Citadel Advisors, each of which indicated an interest in purchasing units sold in our Initial Public Offering and is a member in our sponsor and has an indirect beneficial interest in up to 150,000 founder shares (and one of whom, in addition, has an indirect beneficial interest in 186,666 private placement warrants); and (ii) two investors that expressed an interest to purchase up to 4.9% of the units sold in the Initial Public Offering (excluding the units sold when the underwriters partially exercised the over-allotment option) and each is a member in our sponsor and has an indirect beneficial interest in up to 75,000 founder shares. None of those funds or accounts is a managing member of our sponsor, nor do they have any management authority with respect to our sponsor. Unlike the other participants in the sponsor, the sponsor members are not subject to any lockup restriction on the transfer of their ordinary shares and are not subject to forfeiture or adjustment with respect to their founder shares received in connection with their purchase of units in the Initial Public Offering, and while they generally agree or will use reasonable best efforts to vote their ordinary shares in favor of the business combination, this voting commitment only applies to ordinary shares still held by them. Further, with respect to units purchased in the Initial Public Offering, the sponsor members have the same rights (including redemption rights) as other public purchasers of units.
64